Literature DB >> 31323433

Repeat-associated RNA structure and aberrant splicing.

Melissa A Hale1, Nicholas E Johnson1, J Andrew Berglund2.   

Abstract

Over 30 hereditary disorders attributed to the expansion of microsatellite repeats have been identified. Despite variant nucleotide content, number of consecutive repeats, and different locations in the genome, many of these diseases have pathogenic RNA gain-of-function mechanisms. The repeat-containing RNAs can form structures in vitro predicted to contribute to the disease through assembly of intracellular RNA aggregates termed foci. The expanded repeat RNAs within these foci sequester RNA binding proteins (RBPs) with important roles in the regulation of RNA metabolism, most notably alternative splicing (AS). These deleterious interactions lead to downstream alterations in transcriptome-wide AS directly linked with disease symptoms. This review summarizes existing knowledge about the association between the repeat RNA structures and RBPs as well as the resulting aberrant AS patterns, specifically in the context of myotonic dystrophy. The connection between toxic, structured RNAs and dysregulation of AS in other repeat expansion diseases is also discussed. This article is part of a Special Issue entitled: RNA structure and splicing regulation edited by Francisco Baralle, Ravindra Singh and Stefan Stamm.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Muscleblind-like (MBNL); Myotonic dystrophy; RNA binding proteins; RNA structure; Repeat expansion diseases

Mesh:

Substances:

Year:  2019        PMID: 31323433      PMCID: PMC7099610          DOI: 10.1016/j.bbagrm.2019.07.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  198 in total

Review 1.  Fuchs Corneal Dystrophy.

Authors:  Allen O Eghrari; S Amer Riazuddin; John D Gottsch
Journal:  Prog Mol Biol Transl Sci       Date:  2015-07-15       Impact factor: 3.622

2.  The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.

Authors:  Kaalak Reddy; Bita Zamiri; Sabrina Y R Stanley; Robert B Macgregor; Christopher E Pearson
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

3.  Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.

Authors:  J W Day; K Ricker; J F Jacobsen; L J Rasmussen; K A Dick; W Kress; C Schneider; M C Koch; G J Beilman; A R Harrison; J C Dalton; L P W Ranum
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

4.  Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.

Authors:  D E Moller; A Yokota; J F Caro; J S Flier
Journal:  Mol Endocrinol       Date:  1989-08

Review 5.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

6.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 7.  SR Proteins: Binders, Regulators, and Connectors of RNA.

Authors:  Sunjoo Jeong
Journal:  Mol Cells       Date:  2017-01-26       Impact factor: 5.034

8.  rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.

Authors:  Chantal Sellier; Estefanía Cerro-Herreros; Markus Blatter; Fernande Freyermuth; Angeline Gaucherot; Frank Ruffenach; Partha Sarkar; Jack Puymirat; Bjarne Udd; John W Day; Giovanni Meola; Guillaume Bassez; Harutoshi Fujimura; Masanori P Takahashi; Benedikt Schoser; Denis Furling; Ruben Artero; Frédéric H T Allain; Beatriz Llamusi; Nicolas Charlet-Berguerand
Journal:  Nat Commun       Date:  2018-05-22       Impact factor: 14.919

9.  Identification and characterization of RNA guanine-quadruplex binding proteins.

Authors:  Annekathrin von Hacht; Oliver Seifert; Marcus Menger; Tatjana Schütze; Amit Arora; Zoltán Konthur; Peter Neubauer; Anke Wagner; Christoph Weise; Jens Kurreck
Journal:  Nucleic Acids Res       Date:  2014-04-25       Impact factor: 16.971

10.  RNA phase transitions in repeat expansion disorders.

Authors:  Ankur Jain; Ronald D Vale
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

View more
  9 in total

1.  RNA structure and splicing regulation.

Authors:  Francisco E Baralle; Ravindra N Singh; Stefan Stamm
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-11-12       Impact factor: 4.490

2.  Changes in the Small Noncoding RNAome During M1 and M2 Macrophage Polarization.

Authors:  Ding Ma; Xing Zhou; Yu Wang; Liming Dai; Jie Yuan; Jianping Peng; Xiaoling Zhang; Chuandong Wang
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

Review 3.  RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration.

Authors:  Lydia M Castelli; Bridget C Benson; Wan-Ping Huang; Ya-Hui Lin; Guillaume M Hautbergue
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

4.  A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex.

Authors:  Alicia J Angelbello; Raphael I Benhamou; Suzanne G Rzuczek; Shruti Choudhary; Zhenzhi Tang; Jonathan L Chen; Madhuparna Roy; Kye Won Wang; Ilyas Yildirim; Albert S Jun; Charles A Thornton; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2020-11-05       Impact factor: 8.116

Review 5.  Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.

Authors:  Dunhui Li; Craig Stewart McIntosh; Frank Louis Mastaglia; Steve Donald Wilton; May Thandar Aung-Htut
Journal:  Transl Neurodegener       Date:  2021-05-20       Impact factor: 8.014

6.  Selection of Olduvai Domains during Evolution: A Role for Primate-Specific Splicing Super-Enhancer and RNA Guanine Quadruplex in Bipartite NBPF Exons.

Authors:  Igor Vořechovský
Journal:  Brain Sci       Date:  2022-06-30

7.  A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.

Authors:  Sarah Wagner-Griffin; Masahito Abe; Raphael I Benhamou; Alicia J Angelbello; Kamalakannan Vishnu; Jonathan L Chen; Jessica L Childs-Disney; Matthew D Disney
Journal:  J Med Chem       Date:  2021-06-08       Impact factor: 8.039

8.  SRSF5 regulates alternative splicing of DMTF1 pre-mRNA through modulating SF1 binding.

Authors:  Jialiang Li; Guangyue Li; Yige Qi; Yao Lu; Hao Wang; Ke Shi; Dangdang Li; Jinming Shi; Daniel B Stovall; Guangchao Sui
Journal:  RNA Biol       Date:  2021-07-22       Impact factor: 4.766

Review 9.  Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies.

Authors:  Joshua L Schwartz; Krysten Leigh Jones; Gene W Yeo
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-11-10       Impact factor: 8.250

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.